VIRTUALMAG: Effect of Virtual Reality for Pain Management During Intracervical Balloon Placement for Artificial Childbirth Induction

Sponsor
Centre Hospitalier Universitaire de Saint Etienne (Other)
Overall Status
Recruiting
CT.gov ID
NCT05155826
Collaborator
(none)
56
1
2
10
5.6

Study Details

Study Description

Brief Summary

The labor induction concerns 22% of births in France. In the event of labor induction, in almost two thirds of cases, a cervical ripening method is used and the use of mechanical methods is observed for 8% of cervical ripening. Intra-cervical balloon placement is generally well tolerated but is frequently associated with pain and acute anxiety. There are few options for pain relief. Virtual reality, a relatively new intervention, has been studied as a distraction technique for pain relief, but never in the context of the induction of childbirth.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual Reality Headset
N/A

Detailed Description

It's prospective single-center, randomized, single-blind, prospective study (1:1, 2 group randomization) comparing a group of patients who benefited from the use of the virtual reality headset to a group of patients who received standard care during balloon insertion. Two groups of patients will be formed: a "standard care" group and a "standard care + virtual reality" group.

The study will take place at the Saint-Etienne University Hospital Center in the gynecology-obstetrics department.

The principal objective is to evaluate the effectiveness of the use of a virtual reality helmet on the reduction of pain during the insertion of an intra-cervical balloon for childbirth induction versus the use of standard care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This is a prospective monocentric study, randomized in 2 parallel groups, evaluating the effectiveness of the use of a virtual reality headset on the reduction of pain during intra-cervical balloon insertion for induction versus standard care.This is a prospective monocentric study, randomized in 2 parallel groups, evaluating the effectiveness of the use of a virtual reality headset on the reduction of pain during intra-cervical balloon insertion for induction versus standard care.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Virtual Reality for Pain Management During Intracervical Balloon Placement for Labor Induction: a Randomized Controlled Trial (VIRTUALMAG)
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: standard care (control group)

Patient benefit the standard care during the placement of Cook's balloon (standard care).

Experimental: standard care and virtual reality (experimental group)

Patient benefit the standard care during placement of Cook's balloon (standard care) with the use of a virtual reality.

Device: Virtual Reality Headset
The patient will benefit from the placement of Cook's balloon (standard care) with the placement of the virtual reality headset on the examination table with the launch of the software before the beginning of the procedure. The virtual reality helmet will be removed at the end of the procedure.
Other Names:
  • Deepsen® VRx and Shenzhen Huajin® electronics Co
  • Outcome Measures

    Primary Outcome Measures

    1. maximum pain felt during balloon placement [Day: 0]

      Measurement of the maximum pain experienced during the placement of the intra-cervical balloon using a numerical scale from 0 to 10: 0 = no pain, 10 = maximum pain.

    Secondary Outcome Measures

    1. average pain felt during balloon placement [Day: 0]

      Average pain felt during balloon placement measured by a numerical scale from 0 to 10. (0 no pain - 10 maximum pain).

    2. Nociception Level Index (NOL™) during balloon placement [Day: 0]

      Measured Nociception Level Index (NOL ™) calculated by the PMD200 Pain Monitor™. Nociception Level Index is numerical index from 0 to 100. (>25 = pain)

    3. Anxiety felt during balloon placement [Day: 0]

      Anxiety felt during balloon placement measured by a numerical scale from 0 to 10 : 0 = no anxiety - 10 = maximum anxiety.

    4. difficulty of balloon placement by the midwife during induction of labor [Day: 0]

      Difficulty of balloon placement by the midwife is measured by questionary classified as very easy / easy / ni easy ni difficult / difficult / very difficult

    5. patient's satisfaction with the use of the virtual reality headset. [Day: 0]

      patient's satisfaction is evaluated by Likert scale: Completely satisfied/ Satisfied/ Neutral/ Not satisfied/ Not at all satisfied

    6. midwife's satisfaction with the use of the virtual reality headset. [Day: 0]

      midwife's satisfaction is evaluated by Likert scale: Completely satisfied/ Satisfied/ Neutral/ Not satisfied/ Not at all satisfied

    7. tolerance of the virtual reality helmet by the patient. [Day: 0]

      Tolerance is a composite outcome : nausea (YES/NO), dizziness (YES/NO), premature stopping (YES/NO)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Any pregnant woman presenting to the Gynecology-Obstetrics Department of the Saint-Etienne University Hospital for an induction by Cook's balloon.

    • Patients affiliated or entitled to a social security system

    • Patients having given their agreement to participate and after signing the consent form

    Exclusion Criteria:
    • Woman refusing to participate in the study (lack of consent)

    • Non French-speaking woman (impossibility of carrying out a good quality interview of the pregnant woman)

    • Women suffering from blindness, deafness or epilepsy against the use of the virtual reality helmet.

    • Participation in another interventional study.

    • Patient under guardianship or curatorship

    • Patient subject to a legal protection measure or unable to express their consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU de Saint-Etienne Saint-Étienne France 42055

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire de Saint Etienne

    Investigators

    • Principal Investigator: Tiphaine RAIA BARJAT, MD, CHU SAINT ETIENNE

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Universitaire de Saint Etienne
    ClinicalTrials.gov Identifier:
    NCT05155826
    Other Study ID Numbers:
    • 21CH027
    • ANSM
    First Posted:
    Dec 14, 2021
    Last Update Posted:
    Feb 10, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Centre Hospitalier Universitaire de Saint Etienne
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 10, 2022